|
1
|
Fearon K, Strasser F, Anker SD, Bosaeus I,
Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, et al: Definition and classification of cancer
cachexia: An international consensus. Lancet Oncol. 12:489–495.
2011. View Article : Google Scholar
|
|
2
|
Donohoe CL, Ryan AM and Reynolds JV:
Cancer cachexia: Mechanisms and clinical implications.
Gastroenterol Res Pract. 2011:6014342011. View Article : Google Scholar
|
|
3
|
Yoshida T, Semprun-Prieto L, Sukhanov S
and Delafontaine P: IGF-1 prevents ANG II-induced skeletal muscle
atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin
ligase atrogin-1 expression. Am J Physiol Heart Circ Physiol.
298:H1565–H1570. 2010. View Article : Google Scholar
|
|
4
|
Lin XY and Chen SZ: Calpain inhibitors
ameliorate muscle wasting in a cachectic mouse model bearing CT26
colorectal adenocarcinoma. Oncol Rep. 37:1601–1610. 2017.
View Article : Google Scholar
|
|
5
|
Johns N, Stephens NA and Fearon KC: Muscle
wasting in cancer. Int J Biochem Cell Biol. 45:2215–2229. 2013.
View Article : Google Scholar
|
|
6
|
Tsubouchi H, Yanagi S, Miura A, Matsumoto
N, Kangawa K and Nakazato M: Ghrelin relieves cancer cachexia
associated with the development of lung adenocarcinoma in mice. Eur
J Pharmacol. 743:1–10. 2014. View Article : Google Scholar
|
|
7
|
Penna F, Costamagna D, Pin F, Camperi A,
Fanzani A, Chiarpotto EM, Cavallini G, Bonelli G, Baccino FM and
Costelli P: Autophagic degradation contributes to muscle wasting in
cancer cachexia. Am J Pathol. 182:1367–1378. 2013. View Article : Google Scholar
|
|
8
|
Goll DE, Neti G, Mares SW and Thompson VF:
Myofibrillar protein turnover: The proteasome and the calpains. J
Anim Sci. 86 (Suppl):E19–E35. 2008. View Article : Google Scholar
|
|
9
|
Dókus LE, Yousef M and Bánóczi Z:
Modulators of calpain activity: Inhibitors and activators as
potential drugs. Expert Opin Drug Discov. 15:471–486. 2020.
View Article : Google Scholar
|
|
10
|
Huang J and Zhu X: The molecular
mechanisms of calpains action on skeletal muscle atrophy. Physiol
Res. 65:547–560. 2016. View Article : Google Scholar
|
|
11
|
Ozaki T, Tomita H, Tamai M and Ishiguro S:
Characteristics of mitochondrial calpains. J Biochem. 142:365–376.
2007. View Article : Google Scholar
|
|
12
|
Goll DE, Thompson VF, Li H, Wei W and Cong
J: The calpain system. Physiol Rev. 83:731–801. 2003. View Article : Google Scholar
|
|
13
|
Chen Q, Thompson J, Hu Y, Dean J and
Lesnefsky EJ: Inhibition of the ubiquitous calpains protects
complex I activity and enables improved mitophagy in the heart
following ischemia-reperfusion. Am J Physiol Cell Physiol.
317:C910–C921. 2019. View Article : Google Scholar
|
|
14
|
Kar P, Chakraborti T, Roy S, Choudhury R
and Chakraborti S: Identification of calpastatin and mu-calpain and
studies of their association in pulmonary smooth muscle
mitochondria. Arch Biochem Biophys. 466:290–299. 2007. View Article : Google Scholar
|
|
15
|
Tisdale MJ: Mechanisms of cancer cachexia.
Physiol Rev. 89:381–410. 2009. View Article : Google Scholar
|
|
16
|
Zeng X, Chen S, Yang Y and Ke Z: Acylated
and unacylated ghrelin inhibit atrophy in myotubes co-cultured with
colon carcinoma cells. Oncotarget. 8:72872–72885. 2017. View Article : Google Scholar
|
|
17
|
Trendelenburg AU, Meyer A, Rohner D, Boyle
J, Hatakeyama S and Glass DJ: Myostatin reduces Akt/TORC1/p70S6K
signaling, inhibiting myoblast differentiation and myotube size. Am
J Physiol Cell Physiol. 296:C1258–C1270. 2009. View Article : Google Scholar
|
|
18
|
Zhang XL, Wang ZZ, Shao QH, Zhang Z, Li L,
Guo ZY, Sun HM, Zhang Y and Chen NH: RNAi-mediated knockdown of
DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3β and JNK
signaling pathways in dopaminergic neuron-like cells. Brain Res
Bull. 146:228–236. 2019. View Article : Google Scholar
|
|
19
|
Zeng X, Chen S, Lin Y and Ke Z: Acylated
and unacylated ghrelin inhibit apoptosis in myoblasts cocultured
with colon carcinoma cells. Oncol Rep. 39:1387–1395. 2018.
|
|
20
|
Thompson J, Hu Y, Lesnefsky EJ and Chen Q:
Activation of mitochondrial calpain and increased cardiac injury:
Beyond AIF release. Am J Physiol Heart Circ Physiol. 310:H376–H384.
2016. View Article : Google Scholar
|
|
21
|
Hendriks KDW, Joschko CP, Hoogstra-Berends
F, Heegsma J, Faber KN and Henning RH: Hibernator-derived cells
show superior protection and survival in hypothermia compared to
non-hibernator cells. Int J Mol Sci. 9:18642020. View Article : Google Scholar
|
|
22
|
Kudo-Sakamoto Y, Akazawa H, Ito K, Takano
J, Yano M, Yabumoto C, Naito AT, Oka T, Lee JK, Sakata Y, et al:
Calpain-dependent cleavage of N-cadherin is involved in the
progression of post-myocardial infarction remodeling. J Biol Chem.
289:19408–19419. 2014. View Article : Google Scholar
|
|
23
|
Fakharnia F, Khodagholi F, Dargahi L and
Ahmadiani A: Prevention of cyclophilin D-mediated mPTP opening
using cyclosporine-A alleviates the elevation of necroptosis,
autophagy and apoptosis-related markers following global cerebral
ischemia-reperfusion. J Mol Neurosci. 61:52–60. 2017. View Article : Google Scholar
|
|
24
|
Cao G, Xing J, Xiao X, Liou AK, Gao Y, Yin
XM, Clark RS, Graham SH and Chen J: Critical role of calpain I in
mitochondrial release of apoptosis-inducing factor in ischemic
neuronal injury. J Neurosci. 27:9278–9293. 2007. View Article : Google Scholar
|
|
25
|
Polster BM, Basañez G, Etxebarria A,
Hardwick JM and Nicholls DG: Calpain I induces cleavage and release
of apoptosis-inducing factor from isolated mitochondria. J Biol
Chem. 280:6447–6454. 2005. View Article : Google Scholar
|
|
26
|
Clavel S, Siffroi-Fernandez S, Coldefy AS,
Boulukos K, Pisani DF and Dérijard B: Regulation of the
intracellular localization of Foxo3a by stress-activated protein
kinase signaling pathways in skeletal muscle cells. Mol Cell Biol.
30:470–480. 2010. View Article : Google Scholar
|
|
27
|
Argilés JM, Busquets S, Stemmler B and
López-Soriano FJ: Cancer cachexia: Understanding the molecular
basis. Nat Rev Cancer. 14:754–762. 2014. View Article : Google Scholar
|
|
28
|
Fearon KC, Glass DJ and Guttridge DC:
Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell
Metab. 16:153–166. 2012. View Article : Google Scholar
|
|
29
|
Lokireddy S, Wijesoma I, Bonala S, Wei M,
Sze S, McFarlane C, Kambadur R and Sharma M: Retraction: Myostatin
is a novel tumoral factor that induces cancer cachexia. Biochem J.
473:11112016. View Article : Google Scholar
|
|
30
|
Sun R, Zhang S, Hu W, Lu X, Lou N, Yang Z,
Chen S, Zhang X and Yang H: Valproic acid attenuates skeletal
muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression
in cancer cachexia. Am J Physiol Cell Physiol. 311:C101–C115. 2016.
View Article : Google Scholar
|
|
31
|
Karamanlidis G, Lee CF, Garcia-Menendez L,
Kolwicz SC Jr, Suthammarak W, Gong G, Sedensky MM, Morgan PG, Wang
W and Tian R: Mitochondrial complex I deficiency increases protein
acetylation and accelerates heart failure. Cell Metab. 18:239–250.
2013. View Article : Google Scholar
|
|
32
|
Hollander JM, Thapa D and Shepherd DL:
Physiological and structural differences in spatially distinct
subpopulations of cardiac mitochondria: Influence of cardiac
pathologies. Am J Physiol Heart Circ Physiol. 307:H1–H14. 2014.
View Article : Google Scholar
|
|
33
|
Galkin A, Abramov AY, Frakich N, Duchen MR
and Moncada S: Lack of oxygen deactivates mitochondrial complex I:
Implications for ischemic injury? J Biol Chem. 284:36055–36061.
2009. View Article : Google Scholar
|
|
34
|
Halestrap AP: What is the mitochondrial
permeability transition pore? J Mol Cell Cardiol. 46:821–831. 2009.
View Article : Google Scholar
|
|
35
|
Ding WX, Shen HM and Ong CN: Calpain
activation after mitochondrial permeability transition in
microcystin-induced cell death in rat hepatocytes. Biochem Biophys
Res Commun. 291:321–331. 2002. View Article : Google Scholar
|
|
36
|
Ye H, Cande C, Stephanou NC, Jiang S,
Gurbuxani S, Larochette N, Daugas E, Garrido C, Kroemer G and Wu H:
DNA binding is required for the apoptogenic action of apoptosis
inducing factor. Nat Struct Biol. 9:680–684. 2002. View Article : Google Scholar
|
|
37
|
Glass DJ: Skeletal muscle hypertrophy and
atrophy signaling pathways. Int J Biochem Cell Biol. 37:1974–1984.
2005. View Article : Google Scholar
|
|
38
|
Sandri M: Signaling in muscle atrophy and
hypertrophy. Physiology (Bethesda). 23:160–170. 2008.
|
|
39
|
Tardif N, Klaude M, Lundell L, Thorell A
and Rooyackers O: Autophagic-lysosomal pathway is the main
proteolytic system modified in the skeletal muscle of esophageal
cancer patients. Am J Clin Nutr. 98:1485–1492. 2013. View Article : Google Scholar
|
|
40
|
Yoshida M, Miyasaka Y, Ohuchida K, Okumura
T, Zheng B, Torata N, Fujita H, Nabae T, Manabe T, Shimamoto M, et
al: Calpain inhibitor calpeptin suppresses pancreatic cancer by
disrupting cancer-stromal interactions in a mouse xenograft model.
Cancer Sci. 107:1443–1452. 2016. View Article : Google Scholar
|
|
41
|
Tsujinaka T, Kajiwara Y, Kambayashi J,
Sakon M, Higuchi N, Tanaka T and Mori T: Synthesis of a new cell
penetrating calpain inhibitor (calpeptin). Biochem Biophys Res
Commun. 153:1201–1208. 1988. View Article : Google Scholar
|
